Logo image of AIMD

AINOS INC (AIMD) Stock Price, Forecast & Analysis

USA - NASDAQ:AIMD - US00902F4028 - Common Stock

3.26 USD
-0.02 (-0.61%)
Last: 11/5/2025, 5:40:20 PM

AIMD Key Statistics, Chart & Performance

Key Statistics
Market Cap15.55M
Revenue(TTM)110.90K
Net Income(TTM)-15724300
Shares4.77M
Float1.90M
52 Week High5
52 Week Low2
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-5.27
PEN/A
Fwd PEN/A
Earnings (Next)03-05 2026-03-05
IPO1996-08-08
Sector
GICS IndustryTechnology Hardware, Storage & Peripherals
GICS IndustryGroupTechnology Hardware & Equipment


AIMD short term performance overview.The bars show the price performance of AIMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

AIMD long term performance overview.The bars show the price performance of AIMD in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60

The current stock price of AIMD is 3.26 USD. In the past month the price decreased by -18.7%. In the past year, price increased by 35.89%.

AINOS INC / AIMD Daily stock chart

AIMD Latest News, Press Relases and Analysis

AIMD Competitors/Peers

The largest stocks on the US markets in the "Technology Hardware, Storage & Peripherals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
AAPL APPLE INC 36.16 4008.98B
DELL DELL TECHNOLOGIES -C 19.08 102.15B
STX SEAGATE TECHNOLOGY HOLDINGS 30.2 58.73B
WDC WESTERN DIGITAL CORP 24.37 54.88B
PSTG PURE STORAGE INC - CLASS A 58.09 31.88B
HPE HEWLETT PACKARD ENTERPRISE 12.54 31.28B
SNDK SANDISK CORP N/A 31.72B
SMCI SUPER MICRO COMPUTER INC 25.17 24.98B
HPQ HP INC 8.51 24.90B
NTAP NETAPP INC 15.94 23.09B
LOGI LOGITECH INTERNATIONAL-REG 22.72 19.11B
IONQ IONQ INC N/A 19.25B

About AIMD

Company Profile

AIMD logo image Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in San Diego, California and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.

Company Info

AINOS INC

8880 Rio San Diego Drive, Ste. 800

San Diego CALIFORNIA US

Employees: 44

AIMD Company Website

AIMD Investor Relations

Phone: 18588692986

AINOS INC / AIMD FAQ

Can you describe the business of AINOS INC?

Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in San Diego, California and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.


What is the stock price of AINOS INC today?

The current stock price of AIMD is 3.26 USD. The price decreased by -0.61% in the last trading session.


Does AINOS INC pay dividends?

AIMD does not pay a dividend.


How is the ChartMill rating for AINOS INC?

AIMD has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the sector and industry classification for AINOS INC?

AINOS INC (AIMD) operates in the Information Technology sector and the Technology Hardware, Storage & Peripherals industry.


Would investing in AINOS INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AIMD.


Can you provide the number of employees for AINOS INC?

AINOS INC (AIMD) currently has 44 employees.


AIMD Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to AIMD. When comparing the yearly performance of all stocks, AIMD is one of the better performing stocks in the market, outperforming 82.97% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AIMD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AIMD. AIMD may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AIMD Financial Highlights

Over the last trailing twelve months AIMD reported a non-GAAP Earnings per Share(EPS) of -5.27. The EPS increased by 66.76% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -65.73%
ROE -137.42%
Debt/Equity 0.96
Chartmill High Growth Momentum
EPS Q2Q%59.55%
Sales Q2Q%N/A
EPS 1Y (TTM)66.76%
Revenue 1Y (TTM)83%

AIMD Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

AIMD Ownership

Ownership
Inst Owners0.13%
Ins Owners27.38%
Short Float %0.65%
Short Ratio0.16